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SCIENTIFIC OPINION 
Scientific Opinion on the substantiation of a health claim related to 
a combination of lycopene, vitamin E, lutein and selenium and protection of 
the skin from UV-induced (including photo-oxidative) damage 
pursuant to Article 13(5) of Regulation (EC) No 1924/2006
1
 
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
2
 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Following an application from Nutrilinks Sarl, submitted pursuant to Article 13(5) of Regulation (EC) No 
1924/2006 via the Competent Authority of Cyprus, the Panel on Dietetic Products, Nutrition and Allergies 
(NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to a combination 
of lycopene, vitamin E, lutein and selenium and protection of the skin from UV-induced (including photo-
oxidative) damage. The Panel considers that the combination of lycopene, vitamin E, lutein and selenium is 
sufficiently characterised. The claimed effect refers to the photo-protective activity of the food, delaying the 
appearance of UV-induced erythema and decreasing its intensity. The target population proposed by the 
applicant is healthy adults in the general population, and in particular people with sensitive skin. The Panel 
considers that protection of the skin from UV-induced (including photo-oxidative) damage is a beneficial 
physiological effect. The applicant identified one bioequivalence study as being pertinent to the health claim. The 
Panel notes that this study did not assess direct measures of UV-induced (including photo-oxidative) skin 
damage. Therefore, no conclusions could be drawn from this study for the scientific substantiation of the claim. 
The Panel concludes that a cause and effect relationship has not been established between the consumption of a 
combination of lycopene, vitamin E, lutein and selenium and protection of the skin from UV-induced (including 
photo-oxidative) damage. © European Food Safety Authority, 2012 
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1  On request from the Competent Authority of Cyprus following an application by Nutrilinks Sarl, Question No EFSA-Q-
2012-00592, adopted on 13 September 2012. 
2  Panel members: Carlo Agostoni, Roberto Berni Canani, Susan Fairweather-Tait, Marina Heinonen, Hannu Korhonen, 
Sébastien La Vieille, Rosangela Marchelli, Ambroise Martin, Androniki Naska, Monika Neuhäuser-Berthold, Grażyna 
Nowicka, Yolanda Sanz, Alfonso Siani, Anders Sjödin, Martin Stern, Sean (J.J.) Strain, Inge Tetens, Daniel Tomé, 
Dominique Turck and Hans Verhagen. Correspondence: nda@efsa.europa.eu 
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SUMMARY 
Following an application from Nutrilinks Sarl, submitted pursuant to Article 13(5) of Regulation (EC) 
No 1924/2006 via the Competent Authority of Cyprus, the Panel on Dietetic Products, Nutrition and 
Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim 
related to a combination of lycopene, vitamin E, lutein and selenium and protection of the skin from 
UV-induced (including photo-oxidative) damage. 
The scope of the application was proposed to fall under a health claim based on newly developed 
scientific evidence. 
The food that is the subject of the health claim is a combination of lycopene, vitamin E, lutein and 
selenium. These components are well-characterised and can be analysed in foods by established 
methods. The Panel considers that the combination of lycopene, vitamin E, lutein and selenium is 
sufficiently characterised. 
The claimed effect refers to the photo-protective activity of the food, delaying the appearance of 
UV-induced erythema and decreasing its intensity. The target population proposed by the applicant is 
healthy adults in the general population, and in particular people with sensitive skin. The Panel 
considers that protection of the skin from UV-induced (including photo-oxidative) damage is a 
beneficial physiological effect. 
The applicant identified one human intervention study as being pertinent to the health claim. 
This double-blind, parallel, 10-week study was a bioequivalence study of two oral “antioxidant 
formulas” and their purported protective effects against UV radiation. Fifty Caucasian men and 
women took a placebo for three weeks (i.e. run-in period) and were then randomised to receive for 
seven further weeks either a supplement designated as “current formula” (6 mg lycopene, 6 mg beta-
carotene, 10 mg vitamin E and 75 µg selenium), or the food which is the subject of the health claim 
(“new formula”). Outcome measures of the study were minimal erythemal dose, Individual Typology 
Angle (i.e. colorimetric measurements), melanin content (i.e. percentage of epidermis occupied by 
melanin) and “capping” (i.e. assembling of melanosomes at keratinocytes’ upper poles). 
The Panel notes that erythema is an inflammatory response of the skin to UV-induced molecular and 
cellular damage. A reduction in UV-induced erythema (e.g. measured as change in minimal erythemal 
dose or erythema grade) may indicate less UV-induced damage to the skin, but it can also reflect a 
reduction in the capacity of the skin to react to molecular and cellular damage. Therefore, UV-
induced erythema cannot be used alone as an outcome measure for the substantiation of the claim. 
The other outcomes (i.e. Individual Typology Angle, melanin content and “capping”) used in the 
study did not provide any information on UV-induced skin damage. 
The Panel notes that the submitted study was a bioequivalence study that did not assess direct 
measures of UV-induced (including photo-oxidative) skin damage. The Panel considers that no 
conclusions can be drawn from this study for the scientific substantiation of the claim. 
The Panel notes that no studies were provided from which conclusions could be drawn for the 
scientific substantiation of the claim. 
The Panel concludes that a cause and effect relationship has not been established between the 
consumption of a combination of lycopene, vitamin E, lutein and selenium and protection of the skin 
from UV-induced (including photo-oxidative) damage. 
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BACKGROUND 
Regulation (EC) No 1924/2006
3
 harmonises the provisions that relate to nutrition and health claims, 
and establishes rules governing the Community authorisation of health claims made on foods. As a 
rule, health claims are prohibited unless they comply with the general and specific requirements of 
this Regulation, are authorised in accordance with this Regulation, and are included in the lists of 
authorised claims provided for in Articles 13 and 14 thereof. In particular, Article 13(5) of this 
Regulation lays down provisions for the addition of claims (other than those referring to the reduction 
of disease risk and to children’s development and health) which are based on newly developed 
scientific evidence, or which include a request for the protection of proprietary data, to the 
Community list of permitted claims referred to in Article 13(3). 
According to Article 18 of this Regulation, an application for inclusion in the Community list of 
permitted claims referred to in Article 13(3) shall be submitted by the applicant to the national 
competent authority of a Member State, which will make the application and any supplementary 
information supplied by the applicant available to the European Food Safety Authority (EFSA). 
STEPS TAKEN BY EFSA  
 The application was received on 21/05/2012. 
 The scope of the application was proposed to fall under a health claim based on newly 
developed scientific evidence. 
 The scientific evaluation procedure started on 30/06/2012. 
 During its meeting on 13/09/2012, the NDA Panel, having evaluated the data submitted, 
adopted an opinion on the scientific substantiation of a health claim related to a combination 
of lycopene, vitamin E, lutein and selenium and protection of the skin from UV-induced 
(including photo-oxidative) damage. 
TERMS OF REFERENCE 
EFSA is requested to evaluate the scientific data submitted by the applicant in accordance with 
Article 16(3) of Regulation (EC) No 1924/2006. On the basis of that evaluation, EFSA will issue an 
opinion on the scientific substantiation of a health claim related to: a combination of lycopene, 
vitamin E, lutein and selenium and protection of the skin from UV-induced (including photo-
oxidative) damage. 
EFSA DISCLAIMER 
The present opinion does not constitute, and cannot be construed as, an authorisation for the 
marketing of a combination of lycopene, vitamin E, lutein and selenium, a positive assessment of its 
safety, nor a decision on whether a combination of lycopene, vitamin E, lutein and selenium is, or is 
not, classified as a foodstuff. It should be noted that such an assessment is not foreseen in the 
framework of Regulation (EC) No 1924/2006. 
It should also be highlighted that the scope, the proposed wording of the claim, and the conditions of 
use as proposed by the applicant may be subject to changes, pending the outcome of the authorisation 
procedure foreseen in Article 18(4) of Regulation (EC) No 1924/2006. 
                                                     
3  Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and 
health claims made on foods. OJ L 404, 30.12.2006, p. 9–25. 
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INFORMATION PROVIDED BY THE APPLICANT 
Applicant’s name and address: Nutrilinks Sarl, Chemin de Beau-rivage 7, P.O. Box 96, CH-1000 
Lausanne 21, Switzerland. 
Food/constituent as stated by the applicant 
According to the applicant, a food supplement containing lycopene (8 mg), vitamin E (10 mg), lutein 
(1 mg) and selenium (50 µg). 
Health relationship as claimed by the applicant 
According to the applicant, the health claim refers to the photo-protective activity of the food 
supplement, delaying the appearance of UV-induced erythema damages and decreasing its intensity. 
Wording of the health claim as proposed by the applicant 
The applicant has proposed the following wording for the health claim: “helps to prepare sensitive 
skin from the inside to improve their tolerance to the sun”. 
The following alternative wording was proposed: “helps to improve skin tolerance to the sun”. 
Specific conditions of use as proposed by the applicant 
The applicant has proposed a daily intake of 8 mg lycopene, 10 mg vitamin E, 1 mg lutein and 50 µg 
selenium in a food supplement during a meal. The supplementation should start at least one month 
before sun exposure and continue during and after sun exposure. The target population is healthy 
adults in the general population, and in particular people with sensitive skin. 
ASSESSMENT 
1. Characterisation of the food/constituent 
The food that is the subject of the health claim is a combination of lycopene, vitamin E, lutein and 
selenium. 
The amounts contained in one capsule are: 8 mg lycopene (extracted from tomato), 10 mg vitamin E 
(as d-alpha-tocopherol), 1 mg lutein (extracted from Tagetes erecta L.) and 50 µg selenium (as 
sodium selenite). Lycopene, vitamin E, lutein and selenium are well-characterised components and 
can be analysed in foods by established methods. 
Information pertaining to the manufacturing process, batch-to-batch variability and control 
specifications has been provided by the applicant. 
The Panel considers that the food, a combination of lycopene, vitamin E, lutein and selenium, which 
is the subject of the health claim, is sufficiently characterised. 
2. Relevance of the claimed effect to human health 
The claimed effect refers to the photo-protective activity of the food, delaying the appearance of 
UV-induced erythema and decreasing its intensity. The target population proposed by the applicant is 
healthy adults in the general population, and in particular people with sensitive skin. 
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From the information provided, the Panel notes that the claimed effect refers to protection of the skin 
from UV-induced damage, including photo-oxidative damage. 
The Panel considers that protection of the skin from UV-induced (including photo-oxidative) damage 
is a beneficial physiological effect. 
3. Scientific substantiation of the claimed effect 
The applicant performed a literature search in Pubmed, ScienceDirect, Google, Google Scholar, 
IBIDS, Scopus and Scirus using the search terms [(“lutein” AND “lycopene” AND “selenium”) AND 
(“vitamin E” OR “tocopherol”)] AND (“skin tolerance” OR “dermal tolerance” OR “cutaneous 
tolerance”). Studies were included if they were performed with a combination of ingredients identical 
to the food supplement which is the subject of the health claim. No exclusion criteria were specified. 
The Panel notes the limitations of the literature search performed. 
The applicant identified one human intervention study as being pertinent to the health claim. 
This double-blind, parallel, 10-week study (Béjot et al., 2008) was a bioequivalence study of two oral 
“antioxidant formulas” and their purported protective effects against UV radiation. Fifty Caucasian 
men and women of phototype II or III (sex ratio not specified; age range 18-55 years) took a placebo 
(not specified) for three weeks (i.e. run-in period) and were then randomised to receive for seven 
further weeks either a supplement designated as “current formula” (6 mg lycopene, 6 mg beta-
carotene, 10 mg vitamin E and 75 µg selenium; n=25), or the food which is the subject of the health 
claim (“new formula”, n=25). Outcome measures of the study were minimal erythemal dose (MED), 
Individual Typology Angle (i.e. colorimetric measurements), melanin content (i.e. percentage of 
epidermis occupied by melanin) and “capping” (i.e. assembling of melanosomes at keratinocytes’ 
upper poles). 
The Panel notes that erythema is an inflammatory response of the skin to UV-induced molecular and 
cellular damage. A reduction in UV-induced erythema (e.g. measured as change in MED or erythema 
grade (reddening)) may indicate less UV-induced damage to the skin, but it can also reflect a 
reduction in the capacity of the skin to react to molecular and cellular damage. Therefore, 
UV-induced erythema cannot be used alone as an outcome measure for the substantiation of the 
claim. The other outcomes (i.e. Individual Typology Angle, melanin content and “capping”) used in 
the study did not provide any information on UV-induced skin damage. 
The Panel notes that the submitted study was a bioequivalence study that did not assess direct 
measures of UV-induced (including photo-oxidative) skin damage. The Panel considers that no 
conclusions can be drawn from this study for the scientific substantiation of the claim. 
The Panel notes that no studies were provided from which conclusions could be drawn for the 
scientific substantiation of the claim. 
The Panel concludes that a cause and effect relationship has not been established between the 
consumption of a combination of lycopene, vitamin E, lutein and selenium and protection of the skin 
from UV-induced (including photo-oxidative) damage. 
CONCLUSIONS 
On the basis of the data presented, the Panel concludes that: 
 The food, a combination of lycopene, vitamin E, lutein and selenium, which is the subject of 
the health claim, is sufficiently characterised. 
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 The claimed effect refers to the photo-protective activity of the food, delaying the appearance 
of UV-induced erythema and decreasing its intensity. The target population proposed by the 
applicant is healthy adults in the general population, and in particular people with sensitive 
skin. Protection of the skin from UV-induced (including photo-oxidative) damage is a 
beneficial physiological effect. 
 A cause and effect relationship has not been established between the consumption of a 
combination of lycopene, vitamin E, lutein and selenium and protection of the skin from 
UV-induced (including photo-oxidative) damage. 
DOCUMENTATION PROVIDED TO EFSA 
Health claim application on a combination of lycopene, vitamin E, lutein and selenium and protection 
of the skin from UV-induced (including photo-oxidative) damage pursuant to Article 13(5) of 
Regulation (EC) No 1924/2006 (Claim serial No: 0355_CY). May 2012. Submitted by Nutrilinks 
Sarl. 
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MED  minimal erythemal dose 
